Biologics Drug Discovery Market: Global Industry Analysis, Trends, & Forecast 2016-2024

biological drugs market

New York, USA, 2018-Jul-19 — /EPR Network/ —According to Goldstein Research, global biologics drug discovery market is expected to reach USD 140.9 billion by 2024, growing at a CAGR of 12.0% over the forecast period 2016-2024. The huge investments by pharmaceutical companies, diverse diseases like cancer, Parkinson’s and Alzheimer’s, rising geriatric population, increasing healthcare expenditure and well-trained personnel are major driving forces for the growth of global biologics drug discovery market.

Global biologics drug discovery market segmentation has been carried out on the basis of technology and end user. Based on technology, high throughput screening is widely adopted drug discovery technology owing to the market share of almost 40% in the global biologics drug discovery market. Global biologics drug discovery market is dominated by Asia-Pacific due to the high adoption rate of new technology, aggressive investment by pharma industries and favourable government policies.

Browse Full Report: https://www.goldsteinresearch.com/report/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation

On the basis of our in-depth analysis, Global Biologics Drug DiscoveryMarket can be segmented as follows:

By Technology

  • Q-PCR
  • DNA Microarrays
  • Protein Microarrays
  • High-throughput screening
  • Mass Spectrometry
  • Gel Electrophoresis
  • Chromatography
  • Protein and Nucleic Acid Isolation
  • Other technologies

By End User

  • Outsourcing (Contract Research Organization)
  • Insourcing (Within the Organization)

By Region

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Biologics Drug Discovery Industry Analysis” contains the detailed overview of the global biologics drug discovery market. On the basis of our in-depth analysis, a market can be segmented in terms of market segmentation by technology and end user.

Further, for the in-depth analysis, Global Biologics Drug Discovery Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market analysis report also includes competitive outlook of some of the major players profiling of companies such Abbot Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc., Bayer Healthcare AG, GE Healthcare Ltd., Albany Molecular Research Inc., Arqule Inc., AstraZeneca plc, Novartis AG, Luminex Corporation, and Molecular Discovery Ltd.,etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the global biologics drug discovery market trends along with the market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Download Exclusive Sample Request @ https://www.goldsteinresearch.com/request-sample/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.

Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Contact for more Info:

Steve Blade

(Global Sales Head)

USA: + 1-646-568-7747

Canada: +1-437-886-1181

UK: +44-203-318-6627

sales@goldsteinresearch.com

www.goldsteinresearch.com

Browse Similar Reports: Biopolymers Industry

Matched content

Editor’s pick

Express Press Release Distribution